News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN) Said to Consider Actelion Ltd. (ALIOF.PK) Takeover Bid to Gain Rare Disease Drugs


11/17/2010 7:26:00 AM

ZURICH (Reuters) - Shares in Actelion (ATLN.VX) soared on Wednesday on reports that the world's largest biotech firm Amgen (AMGN.O) is studying a takeover offer for the Swiss drugmaker, which says it is in "regular dialogue" with other industry players.

Read at Bloomberg
Read at Trading Markets.com
Read at The Street.com
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES